Multiple sclerosis. Multiple sclerosis
Conditions
Interventions
Intervention 1: Intervention group: Recipient of 3 capsules 500 mg (containing 600 mg lavender) every 8 hours for 2 months. Intervention 2: Control group: Recipient of 3 capsules 500 mg (containing co
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Definitive diagnosis of MS according to McDonald's criteria and confirmed by a neurologist Relapsing-remitting type of MS Having symptoms of fatigue Expanded Disability Status Score (EDSS) of less than or equal to 6 No disease attack during the last month Not using other medication during the study No Depression disease Based on Beck Questionnaire No history of other diseases such as autoimmune disease, malignancy No usind of drugs such as antipsychotic , monoamine oxidase inhibitors, benzodiazepines, tricyclic antidepressants, anticonvulsants and barbiturates
Exclusion criteria
Exclusion criteria: Disease attack during the study The emergence of drug complications Not willingness to continue the study Pregnancy Breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue score on the MFIS questionnaire. Timepoint: At baseline and two months after drug administration. Method of measurement: MFIS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNajmeh Motaghi
Kerman University of Medical Sciences
Outcome results
None listed